Pulmonary embolism epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
{{Pulmonary embolism}}
{{Pulmonary embolism}}
{{CMG}}
{{PE editors}}
'''Associate Editors-in-Chief:''' [[User:Ujjwal Rastogi|Ujjwal Rastogi, MBBS]] [mailto:urastogi@perfuse.org]


==Overview==
==Overview==

Revision as of 16:46, 26 April 2012

Pulmonary Embolism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary Embolism from other Diseases

Epidemiology and Demographics

Risk Factors

Triggers

Natural History, Complications and Prognosis

Diagnosis

Diagnostic criteria

Assessment of Clinical Probability and Risk Scores

Pulmonary Embolism Assessment of Probability of Subsequent VTE and Risk Scores

History and Symptoms

Physical Examination

Laboratory Findings

Arterial Blood Gas Analysis

D-dimer

Biomarkers

Electrocardiogram

Chest X Ray

Ventilation/Perfusion Scan

Echocardiography

Compression Ultrasonography

CT

MRI

Treatment

Treatment approach

Medical Therapy

IVC Filter

Pulmonary Embolectomy

Pulmonary Thromboendarterectomy

Discharge Care and Long Term Treatment

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-Up

Support group

Special Scenario

Pregnancy

Cancer

Trials

Landmark Trials

Case Studies

Case #1

Pulmonary embolism epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary embolism epidemiology and demographics

CDC on Pulmonary embolism epidemiology and demographics

Pulmonary embolism epidemiology and demographics in the news

Blogs on Pulmonary embolism epidemiology and demographics

Directions to Hospitals Treating Pulmonary embolism epidemiology and demographics

Risk calculators and risk factors for Pulmonary embolism epidemiology and demographics

Editor(s)-In-Chief: The APEX Trial Investigators, C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Each year in United States, there are between 300,000-600,000 cases of pulmonary embolism (PE). If left untreated almost one-third of patients die, typically from recurrent PE. However, with prompt diagnosis and treatment, the mortality rate is only approximately 2–8%. Unfortunately, two-thirds of all cases of PE are diagnosed only on autopsy. [1] PE is the major contributing factor or a cause of death in 16% of the hospitalized patients.

Epidemiology and Demographics

  • Horlander et al analyzed multiple-cause mortality files compiled by the National Center for Health Statistics from 1979 to 1998. They reported that out of 42,932,973 deaths that occurred, almost 600,000 patients (approximately 1.5 percent) had been diagnosed with PE. They also theorized it was the presumed cause of death in 200,000 patients.[2]
  • Only 10-20% of VTE is clinically recognized, as depicted by the figure below.

Gender

Pulmonary embolism can occur in any gender.

Age

The prevalence of disease increases with age.

References

  1. American Heart Association. (2007). Venous Thromboembolism & Pulmonary Embolism - Statistical Fact Sheet: 2007 Update. Retreived from http://stopdvt.org/Documents/AMA%20Fact%20Sheet%20Current%20Research.pdf
  2. Horlander KT, Mannino DM, Leeper KV (2003). "Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data". Arch Intern Med. 163 (14): 1711–7. doi:10.1001/archinte.163.14.1711. PMID 12885687.

Template:WH Template:WS